Bengaluru-based nutrition and wellness startup Supply6 has closed a ₹48 crore ($5 million) funding round led by Unilever Ventures, aiming to expand its product lineup and break into new geographic markets. Founded in 2019, Supply6 currently operates at an annualized revenue run rate of ₹75 crore and competes in a booming segment of India's dietary supplements industry.
- ₹48 Cr round led by Unilever Ventures with celebrity investor Kriti Sanon
- Plans to invest in R&D, supply chain, and market expansion
- Operating at ₹75 Cr ARR, expecting ₹100 Cr in coming months
What happened
Supply6, a direct-to-consumer Indian startup specializing in nutrition and wellness supplements, has raised ₹48 crore (about $5 million) in a recent funding round. The round was led by Unilever Ventures and included participation from existing investors such as Zeropearl VC. Actress Kriti Sanon also joined as an investor and brand ambassador, having come on board in December 2025. To date, the startup has raised over $6 million, including a $1.1 million pre-seed round backed by notable entrepreneurs and investors.
Founded in 2019 by Vaibhav Bhandari and Rahul Gupta, Supply6 focuses on daily nutritional supplements combining ingredients like probiotics, micronutrients, and adaptogens in one serving. The startup markets its products through multiple channels including its own website, Amazon, and quick commerce services like Blinkit. Currently, Supply6 reports an annualized revenue run rate of ₹75 crore with expectations to reach ₹100 crore within the next few months.
Why it matters
This funding milestone highlights growing investor confidence in India's nutrition and wellness sector, which is benefiting from rising health awareness and consumer demand for preventative healthcare solutions. The market for dietary supplements in India is poised for significant growth, forecasted to reach $62 billion by 2033 at a CAGR of 13% starting from 2024. Supply6's strategy of offering clinically backed, multi-ingredient products aligns with these market trends, targeting segments such as immunity, fitness, and overall wellness.
Moreover, Supply6’s expansion efforts—including broadening its product portfolio, investing in clinical research, and enhancing supply chain and digital capabilities—will allow the startup to deepen its competitive position against major players like Marico-owned Plix, HUL-owned Oziva, Kapiva, and BeastLife. The involvement of a global corporation like Unilever Ventures further validates Supply6’s growth potential and ambition to scale across various distribution channels including quick commerce.
What to watch next
Looking forward, Supply6 will be focused on executing its plans to expand into new geographic markets and intensify marketing and partnership efforts. Monitoring how effectively the startup leverages the fresh capital to strengthen its omnichannel presence will be key, especially across direct-to-consumer platforms, online marketplaces, and instant delivery services. Progress on clinical research and product innovation will also be critical to differentiate Supply6 in a competitive landscape.
Additionally, consumer uptake and revenue growth over the coming quarters will be important indicators of its scaled operations and market fit. Tracking Supply6’s ability to navigate supply chain enhancements and maintain rapid fulfillment will provide insight into how Indian startups can capitalize on the accelerating demand for convenient, clinically supported nutrition supplements.